Tiotropium+olodaterol shows clinically meaningful improvements in quality of life

Tiotropium+olodaterol improves lung function and symptoms compared to monotherapies in chronic obstructive pulmonary disease (COPD). The OTEMTO 1 and 2 studies investigated the effects of tiotropium+olodaterol on lung function and health-related quality of life compared to placebo in patients with moderate to severe COPD.

Source: Respiratory Medicine CME - August 12, 2015 Category: Respiratory Medicine Authors: Dave Singh, Gary T. Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann, Nathan Bennett, Roger Abrahams, Olaf Schmidt, Leif Bjermer Source Type: research